The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary clinical activity of MEDI0562 in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN).
 
Rom Samuel Leidner
Research Funding - Earle A. Chiles Research Institute (I); MedImmune (Inst)
Patents, Royalties, Other Intellectual Property - Earle A. Chiles Research Institute (I)
 
Sandip Pravin Patel
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - MedImmune (Inst)
 
Matthew G. Fury
Employment - Regeneron (I)
Stock and Other Ownership Interests - Regeneron (I)
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Egenix; Novartis
Research Funding - AstraZeneca/MedImmune; Novartis; Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron (I)
 
Robert L. Ferris
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; VentiRx
 
Jennifer T. McDevitt
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Mark C. Lanasa
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Abbvie; Amgen; Genentech
Research Funding - Celgene (Inst)
 
Bonnie S. Glisson
Research Funding - MedImmune (Inst); Stem CentRx (Inst)